Sign In
Buy ECOR
$6.09
-0.205 (-3.26%)
At Close: Jul 31, 2026
electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026
08:00am, Thursday, 30'th Jul 2026
ROCKAWAY, N.J., July 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial result
Ecora Royalties reports 61% jump in strong quarter
03:25am, Wednesday, 29'th Jul 2026
Ecora Royalties PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF, FRA:HGR) reported that its quarterly portfolio contribution jumped 61% year-on-year to US$19 million, driven by record cobalt receipts from the
New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation
08:00am, Thursday, 16'th Jul 2026
ROCKAWAY, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company and leader in non-invasive vagus nerve stimulation te
electroCore, Inc. (ECOR) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Transcript
04:02pm, Tuesday, 23'rd Jun 2026
electroCore, Inc. (ECOR) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Transcript
electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference
08:00am, Wednesday, 17'th Jun 2026
ROCKAWAY, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will participate in the iAcc
RBC reiterates 'outperform' on Ecora Royalties after Voisey's Bay site visit boosts confidence
10:31am, Monday, 15'th Jun 2026
RBC Capital Markets has reiterated its 'outperform' rating and 185p price target on Ecora Royalties PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF, FRA:HGR) after a site visit to the Voisey's Bay cobalt and co
Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery
08:00am, Tuesday, 09'th Jun 2026
ROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the review article, "Without ge
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
08:00am, Tuesday, 02'nd Jun 2026
ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Plane
electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference
03:03am, Tuesday, 19'th May 2026
electroCore NASDAQ: ECOR Interim President and CFO Joshua Lev said the bioelectronic technology company is focused on expanding its non-invasive vagus nerve stimulation platform across federal health
ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findi
electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026
08:00pm, Friday, 08'th May 2026
ROCKAWAY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the
electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript
05:51am, Thursday, 07'th May 2026
electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript
electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue Estimates
07:36pm, Wednesday, 06'th May 2026
electroCore, Inc. (ECOR) came out with a quarterly loss of $0.59 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.47 per share a year ago.
electroCore Announces First Quarter 2026 Financial Results
04:05pm, Wednesday, 06'th May 2026
First quarter 2026 net sales of $9.6 million, an increase of 43% over $6.7 million in the first quarter 2025 Net loss of $5.3 million with Adjusted EBITDA net loss improving 24% from prior-year period
Ecora Royalties has confirmed a strong start to 2026 - ICYMI
06:22am, Saturday, 02'nd May 2026
Ecora Royalties PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF, FRA:HGR) this week outlined a strong start to 2026, with CEO Marc Bishop Lafleche highlighting significant growth in its base metals portfolio and
